COMP <GO>
TLSI vs SERA // ENTERPRISE SCALE & MARKET CAP
TriSalus Life Sciences Inc. (NASDAQ) VS. Sera Prognostics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: TLSI 4
— SERA 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TLSI
LAST: $3.86 (-1.78%) • MKT CAP: $237.7M
market-cap
$237.7M
LAST: $2.06 (+1.48%) • MKT CAP: $81.3M
market-cap
$81.3M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLSI VS. SERA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TLSI | SERA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.60% | -30.00% | +114.60 | TLSI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.96% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -59.70% | -60.00% | +0.30 | TLSI | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 53.40% | 5.20% | +48.20 | TLSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.4 | 49.4 | -10.91 | SERA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $237.7M | $81.3M | $156.4M | TLSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TLSI REV | SERA REV | TLSI GROSS % | SERA GROSS % | TLSI FCF | SERA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.2M | $81.0K | 84.6% | -50.0% | -$18.9M | -$26.3M |
| FY 2024 | $29.4M | $77.0K | 86.1% | -6.5% | -$41.2M | -$14.2M |
| FY 2023 | $18.5M | $306.0K | — | — | -$50.6M | -$27.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLSI // BETA —
SERA // BETA —